Jianting Long

2.1k total citations
51 papers, 1.2k citations indexed

About

Jianting Long is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jianting Long has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Jianting Long's work include MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Jianting Long is often cited by papers focused on MicroRNA in disease regulation (10 papers), Cancer-related molecular mechanisms research (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Jianting Long collaborates with scholars based in China, United States and Switzerland. Jianting Long's co-authors include Heping Li, Qiangsheng Dai, Baoxian Liu, Chunlin Jiang, Fang Shi, Ruifang Zeng, Ming Kuang, Xiaoyan Xie, Shi Fang and Meihua Qu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jianting Long

50 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianting Long China 20 784 512 290 141 125 51 1.2k
Heping Li China 19 755 1.0× 503 1.0× 232 0.8× 71 0.5× 141 1.1× 47 1.2k
Shaojiang Zheng China 15 626 0.8× 299 0.6× 211 0.7× 146 1.0× 158 1.3× 52 1.1k
Yongfu Xiong China 19 516 0.7× 312 0.6× 254 0.9× 102 0.7× 211 1.7× 56 1.0k
Marta Prieto‐Vila Japan 16 855 1.1× 513 1.0× 504 1.7× 113 0.8× 66 0.5× 20 1.3k
Dong Kuang China 20 525 0.7× 248 0.5× 340 1.2× 157 1.1× 187 1.5× 67 1.2k
Junko Kano Japan 19 527 0.7× 201 0.4× 163 0.6× 132 0.9× 98 0.8× 46 920
Sherry J. Lim United States 12 564 0.7× 343 0.7× 674 2.3× 244 1.7× 140 1.1× 17 1.2k
Zhouyu Ning China 19 500 0.6× 357 0.7× 364 1.3× 116 0.8× 134 1.1× 40 911
Kai Zhu China 16 602 0.8× 335 0.7× 258 0.9× 84 0.6× 320 2.6× 50 1.1k
Fenju Liu China 19 485 0.6× 341 0.7× 260 0.9× 140 1.0× 169 1.4× 42 938

Countries citing papers authored by Jianting Long

Since Specialization
Citations

This map shows the geographic impact of Jianting Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianting Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianting Long more than expected).

Fields of papers citing papers by Jianting Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianting Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianting Long. The network helps show where Jianting Long may publish in the future.

Co-authorship network of co-authors of Jianting Long

This figure shows the co-authorship network connecting the top 25 collaborators of Jianting Long. A scholar is included among the top collaborators of Jianting Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianting Long. Jianting Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chang, et al.. (2024). The Coupled Thermal Response Analysis of Green Roofs Based on the Discrete Element Method. Buildings. 14(12). 3984–3984. 2 indexed citations
3.
Chen, Jingyu, et al.. (2024). Prognostic impact of EGFR mutations in T1–4N0M0 lung adenocarcinoma: analyses focus on imaging and pathological features. Journal of Thoracic Disease. 16(11). 7244–7256.
4.
Yang, Xia, Weizhong Chen, Fang Wang, et al.. (2023). m6A‐Dependent Modulation via IGF2BP3/MCM5/Notch Axis Promotes Partial EMT and LUAD Metastasis. Advanced Science. 10(20). e2206744–e2206744. 31 indexed citations
5.
Xie, Binhui, Zhenxian Zhao, Jie Hu, et al.. (2023). STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 11(1). 26–26. 2 indexed citations
6.
Huang, Manling, Jianting Long, Yi Zhao, et al.. (2022). METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma. Cancer Research. 83(1). 89–102. 138 indexed citations
7.
Long, Jianting, et al.. (2022). miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 4 indexed citations
8.
Liu, Baoxian, Guangliang Huang, Xiaohua Xie, et al.. (2020). Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience. International Journal of Hyperthermia. 37(1). 1202–1209. 6 indexed citations
9.
Shao, Nan, Chuanbo Xie, Yawei Shi, et al.. (2019). <p>Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis</p>. Cancer Management and Research. Volume 11. 1433–1442. 36 indexed citations
10.
Wang, Zongren, Han Xiao, Guangyan Wei, et al.. (2018). Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model. BMC Cancer. 18(1). 1108–1108. 5 indexed citations
11.
Long, Jianting, Chunlin Jiang, Baoxian Liu, et al.. (2017). Maintenance of stemness by miR-589-5p in hepatocellular carcinoma cells promotes chemoresistance via STAT3 signaling. Cancer Letters. 423. 113–126. 48 indexed citations
12.
Sun, Pingping, et al.. (2017). Rapid onset of conjunctivitis associated with overdosing of erlotinib. Journal of Clinical Pharmacy and Therapeutics. 43(2). 296–298. 3 indexed citations
13.
Long, Jianting, et al.. (2016). The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis. Oncotarget. 7(22). 32079–32087. 9 indexed citations
14.
Du, Wei, et al.. (2016). Mechanism of SEMA3B gene silencing and clinical significance in glioma. Genetics and Molecular Research. 15(1). 9 indexed citations
15.
Qu, Meihua, Ruifang Zeng, Shi Fang, et al.. (2014). Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. International Journal of Pharmaceutics. 474(1-2). 112–122. 100 indexed citations
16.
17.
Long, Jianting, Liu Liu, Zaneta Nikolovska‐Coleska, et al.. (2013). Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins. BMC Biotechnology. 13(1). 45–45. 5 indexed citations
18.
Dai, Qiangsheng, et al.. (2013). XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis. Tumor Biology. 35(1). 447–453. 11 indexed citations
20.
Bai, Longchuan, et al.. (2009). Effect of (-)-gossypol (AT-101) on transcriptional regulation of Noxa and Puma and on Mcl-1-mediated cancer cell resistance to apoptosis. Journal of Clinical Oncology. 27(15_suppl). e14611–e14611. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026